menu
    • menu

    Find Riociguat manufacturers, exporters & distributors on PharmaCompass

    Zhejiang Riociguat

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    12

    API Suppliers

    API Suppliers

    3

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    0

    KDMF

    KDMF

    2

    NDC API

    NDC API

    0

    VMF

    NDC API

    10

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 43,291

    MARKET PLACE

    7

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    76

    FDF Dossiers

    FDF Dossiers

    14

    FDA Orange Book

    FDA (Orange Book)

    32

    Europe

    Europe

    10

    Canada

    Canada

    20

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    2

    Others

    PATENTS & EXCLUSIVITIES

    25

    US Patents

    0

    US Exclusivities

    5

    Health Canada Patents

    DIGITAL CONTENT

    2

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    24

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    576,981,088

    Annual Reports

    7,200

    Finished Drug Prices

    Listed Dossiers

    140 RELATED EXCIPIENT COMPANIES

    231EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 625115-55-1, Adempas, Bay 63-2521, Riociguat (bay 63-2521), Bay-63-2521, Ru3fe2y4xi
    Molecular Formula
    C20H19FN8O2
    Molecular Weight
    422.4  g/mol
    InChI Key
    WXXSNCNJFUAIDG-UHFFFAOYSA-N
    FDA UNII
    RU3FE2Y4XI
    Riociguat
    Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for the treatment of patients with inoperable CTEPH (chronic thromboembolic pulmonary hypertension), or persistent/recurrent PH (pulmonary hypertension) after pulmonary endarterectomy in WHO FC II or III. Riociguat is marketed under the brand Adempas by Bayer HealthCare Pharmaceuticals. Treatment with riociguat costs USD $7,500 for 30 days of treatment.
    Riociguat is a Soluble Guanylate Cyclase Stimulator. The mechanism of action of riociguat is as a Guanylate Cyclase Stimulator.
    1 2D Structure

    Riociguat

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
    2.1.2 InChI
    InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26)
    2.1.3 InChI Key
    WXXSNCNJFUAIDG-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC
    2.2 Other Identifiers
    2.2.1 UNII
    RU3FE2Y4XI
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Adempas

    2. Bay 63-2521

    3. Bay-63-2521

    2.3.2 Depositor-Supplied Synonyms

    1. 625115-55-1

    2. Adempas

    3. Bay 63-2521

    4. Riociguat (bay 63-2521)

    5. Bay-63-2521

    6. Ru3fe2y4xi

    7. Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate

    8. Methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-n-methylcarbamate

    9. Chebi:76018

    10. 1304478-72-5

    11. N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-n-methylcarbamic Acid Methyl Ester

    12. Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1h-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-n-methylcarbamate

    13. Methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-n-methylcarbamate

    14. Riociguat [inn]

    15. Methyl ~{n}-[4,6-bis(azanyl)-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-~{n}-methyl-carbamate

    16. Methyl 4,6-diamino-2-(1-(2-fluorobenzyl)-1h-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl(methyl)carbamate

    17. Unii-ru3fe2y4xi

    18. Riociguatum

    19. Riociguate

    20. Riociguat [usan:inn:jan]

    21. Riocguat-d3

    22. Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate

    23. Methyl N-(4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1h-pyrazolo(3,4-b)pyridin-3-yl)pyrimidin-5-yl)-n-methylcarbamate

    24. Adempas (tn)

    25. Bay 632521

    26. Riociguat [jan]

    27. Riociguat [mi]

    28. Riociguat [usan]

    29. Riociguat [vandf]

    30. Riociguat [usp-rs]

    31. Riociguat [who-dd]

    32. Bay 63-2521,riociguat

    33. Riociguat (jan/usan/inn)

    34. Schembl245457

    35. Gtpl5257

    36. Riociguat [orange Book]

    37. Chembl2107834

    38. Riociguat [ep Monograph]

    39. Amy4218

    40. Dtxsid50978109

    41. Riociguat [usp Monograph]

    42. Bcp04750

    43. Bcp23980

    44. Ex-a2023

    45. Zinc3819392

    46. Riociguat,cas:625115-55-1

    47. Mfcd19443708

    48. S8135

    49. Akos015900718

    50. Akos032950011

    51. Bay-632521

    52. Bcp9000382

    53. Ccg-268912

    54. Cs-0584

    55. Db08931

    56. Pb25734

    57. Ncgc00379065-03

    58. Ncgc00379065-04

    59. Ncgc00379065-05

    60. [4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamic Acid Methyl Ester

    61. Ac-27647

    62. As-19299

    63. Hy-14779

    64. Bcp0726000023

    65. Db-073136

    66. Ft-0760451

    67. Bay 63-2521;bay 632521

    68. D09572

    69. Bay 63-2521; Bay 632521

    70. 115r551

    71. Q2154494

    72. Bay 63-2521-d3; Bay 632521-d3; Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamate-d3

    73. Carbamic Acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1h-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)methyl-, Methyl Ester

    74. Carbamic Acid, N-(4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1h-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)-n-methyl-, Methyl Ester

    75. Gzo

    76. Methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate

    77. Methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-n-methyl-carbaminate

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 422.4 g/mol
    Molecular Formula C20H19FN8O2
    XLogP31.6
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count5
    Exact Mass422.16150004 g/mol
    Monoisotopic Mass422.16150004 g/mol
    Topological Polar Surface Area138 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity618
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameAdempas
    PubMed HealthRiociguat (By mouth)
    Drug ClassesCardiovascular Agent
    Drug LabelAdempas (riociguat) is a tablet for oral administration. Riociguat is methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate with the following structural formula:C20H19FN8O2Riociguat is a white to ye...
    Active IngredientRiociguat
    Dosage FormTablet
    RouteOral
    Strength2.5mg; 1.5mg; 0.5mg; 2mg; 1mg
    Market StatusPrescription
    CompanyBayer Hlthcare

    2 of 2  
    Drug NameAdempas
    PubMed HealthRiociguat (By mouth)
    Drug ClassesCardiovascular Agent
    Drug LabelAdempas (riociguat) is a tablet for oral administration. Riociguat is methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridin-3-yl]-5-pyrimidinyl(methyl)carbamate with the following structural formula:C20H19FN8O2Riociguat is a white to ye...
    Active IngredientRiociguat
    Dosage FormTablet
    RouteOral
    Strength2.5mg; 1.5mg; 0.5mg; 2mg; 1mg
    Market StatusPrescription
    CompanyBayer Hlthcare

    4.2 Drug Indication

    Riociguat is indicated for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), (WHO Group 4) after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class. Riociguat is indicated for the treatment of adults with pulmonary arterial hypertension (PAH), (WHO Group 1), to improve exercise capacity, WHO functional class and to delay clinical worsening. Efficacy was shown in patients on Riociguat monotherapy or in combination with endothelin receptor antagonists or prostanoids. Studies establishing effectiveness included predominately patients with WHO functional class IIIII and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (25%).

    FDA Label

    Chronic thromboembolic pulmonary hypertension (CTEPH)

    Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with

    - inoperable CTEPH,

    - persistent or recurrent CTEPH after surgical treatment,

    to improve exercise capacity (see section 5. 1).

    Pulmonary arterial hypertension (PAH)

    Adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the

    treatment of adult patients with pulmonary arterial hypertension (PAH) with WHO Functional Class

    (FC) II to III to improve exercise capacity.

    Efficacy has been shown in a PAH population including aetiologies of idiopathic or heritable PAH or

    PAH associated with connective tissue disease (see section 5. 1).

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Enzyme Activators

    Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)

    5.2 FDA Pharmacological Classification
    5.2.1 Active Moiety
    RIOCIGUAT
    5.2.2 FDA UNII
    RU3FE2Y4XI
    5.2.3 Pharmacological Classes
    Soluble Guanylate Cyclase Stimulator [EPC]; Guanylate Cyclase Stimulators [MoA]
    5.3 ATC Code

    C02KX05

    C - Cardiovascular system

    C02 - Antihypertensives

    C02K - Other antihypertensives

    C02KX - Antihypertensives for pulmonary arterial hypertension

    C02KX05 - Riociguat

    5.4 Absorption, Distribution and Excretion

    Absorption

    The pharmacokinetics of riociguant are dose proportional from 0.5 mg to 2.5 mg. The absolute bioavailability is approximately 94%. After oral administration, peak plasma concentrations were achieved within 1.5 hours. Food does not affect the bioavailability of riociguat.

    Route of Elimination

    Riociguat is eliminated in the urine (40%) and feces (53%), largely as metabolites.

    Volume of Distribution

    Volume of distribution at steady state = 30 L

    5.5 Metabolism/Metabolites

    The active metabolite (M1) of riociguat is 1/3 to 1/10 as potent as riociguat.

    5.6 Biological Half-Life

    About 12 hours in patients and 7 hours in healthy subjects.

    5.7 Mechanism of Action

    Riociguat is a stimulator of soluble guanylate cyclase (sGC), an enzyme in the cardiopulmonary system and the receptor for nitric oxide (NO). When NO binds to sGC, the enzyme catalyzes synthesis of the signaling molecule cyclic guanosine monophosphate (cGMP). Intracellular cGMP plays an important role in regulating processes that influence vascular tone, proliferation, fibrosis and inflammation. Pulmonary hypertension is associated with endothelial dysfunction, impaired synthesis of nitric oxide and insufficient stimulation of the NO-sGC-cGMP pathway. Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding. Riociguat also directly stimulates sGC via a different binding site, independently of NO. Riociguat stimulates the NO-sGC-cGMP pathway and leads to increased generation of cGMP with subsequent vasodilation.

    API SUPPLIERS

    read-more
    read-more

    01

    Zhejiang Hengkang Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI China
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothZhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Zhejiang Hengkang Pharmaceutical

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Metrochem API Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Metrochem

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-06-01

    Pay. Date : 2017-05-18

    DMF Number : 31092

    Submission : 2016-12-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2019-07-26

    Valid Till : 2022-08-08

    Written Confirmation Number : WC-0383

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 69766-021

    Start Marketing Date : 2016-12-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    MSN Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-09-15

    Pay. Date : 2023-08-08

    DMF Number : 38372

    Submission : 2023-07-01

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 69766-021

    Start Marketing Date : 2016-12-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Alembic Pharmaceuticals Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Alembic Pharmaceuticals Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-07-18

    Pay. Date : 2017-06-28

    DMF Number : 31665

    Submission : 2017-06-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-17

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0082

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 46708-894

    Start Marketing Date : 2017-04-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    PRG Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    PRG Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Zhejiang Ausun Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    08

    Maiden Group

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    09

    Micro Labs Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow

    Micro Labs Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PharmaVenue
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Guangzhou Tosun Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PharmaVenue
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"RIOCIGUAT","year":"2021","qtr":"Q1","strtotime":1615314600,"product":"RIOCIGUAT (GROUP:B)(TAX INV NO:591020522 8 DT:28.02.2021","address":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"QILU PHARMACEUTICAL","customerCountry":"CHINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"34713.5","totalValueFC":"10306.6","currency":"USD","unitRateINR":2501106.666666667,"date":"10-Mar-2021","totalValueINR":"750332","totalValueInUsd":"10306.6","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"9264947","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632940200,"product":"RIOCIGUAT (TAX INVOICE NO:5910215112 DT","address":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"MICHAEL BURKE & ","customerCountry":"JORDAN","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"60000","totalValueFC":"5832.3","currency":"USD","unitRateINR":4290000,"date":"30-Sep-2021","totalValueINR":"429000","totalValueInUsd":"5832.3","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"4972424","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634149800,"product":"RIOCIGUAT (TAX INVOICE NO:5910215120 DT","address":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"NEW IN CO. ","customerCountry":"TAIWAN","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"50000","totalValueFC":"9758.1","currency":"USD","unitRateINR":3655000,"date":"14-Oct-2021","totalValueINR":"731000","totalValueInUsd":"9758.1","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"5296380","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635186600,"product":"RIOCIGUAT (GROUP:B)(TAX INV NO:591021513","address":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"SHENZHEN SUNGENING MEDICINE ","customerCountry":"CHINA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"50000","totalValueFC":"9744.8","currency":"USD","unitRateINR":3650000,"date":"26-Oct-2021","totalValueINR":"730000","totalValueInUsd":"9744.8","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"5584497","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635705000,"product":"RIOCIGUAT (GROUP:B)(TAX INV NO:591021513","address":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU GREENSYN PHARMA ","customerCountry":"CHINA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"35000","totalValueFC":"34604","currency":"USD","unitRateINR":2577000,"date":"01-Nov-2021","totalValueINR":"2577000","totalValueInUsd":"34604","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"5758465","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"1ST FLOOR,PLOT NO.497,VIVEKANANDANAGAR COLONY, KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648146600,"product":"RIOCIGUAT (TAX INV NO:5910215276 DT:22.0","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"75000","totalValueFC":"3621.1","currency":"USD","unitRateINR":5520000,"date":"25-Mar-2022","totalValueINR":"276000","totalValueInUsd":"3621.1","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"9199239","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1654540200,"product":"RIOCIGUAT (TAX INVOICE NO:5910225043 DAT","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER OF","customerCountry":"GREECE","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"70","totalValueFC":"10215.9","currency":"USD","unitRateINR":5313.333333333333,"date":"07-Jun-2022","totalValueINR":"797000","totalValueInUsd":"10215.9","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"1960204","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669228200,"product":"RIOCIGUAT-PH.EUR","address":"ALEMBIC ROAD VADODARA Contact No: 919727727339","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER,OF","customerCountry":"TURKEY","quantity":"0.55","actualQuantity":"0.55","unit":"KGS","unitRateFc":"30000","totalValueFC":"16321","currency":"USD","unitRateINR":2421818.1818181816,"date":"24-Nov-2022","totalValueINR":"1332000","totalValueInUsd":"16321","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"5695014","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"ALEMBIC ROAD VADODARA Contact No: 919727727339, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672338600,"product":"RIOCIGUAT-PH.EUR","address":"ALEMBIC ROAD VADODARA CONTACT NO: 919727727339","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO\/ THE ORDER OF","customerCountry":"EGYPT","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"50000","totalValueFC":"2463.4","currency":"USD","unitRateINR":4060000,"date":"30-Dec-2022","totalValueINR":"203000","totalValueInUsd":"2463.4","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"6577665","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"ALEMBIC ROAD VADODARA CONTACT NO: 919727727339, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673461800,"product":"RIOCIGUAT(RG)","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"TO THE ORDER OF,","customerCountry":"CHINA","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"50000","totalValueFC":"941.8","currency":"USD","unitRateINR":3850000,"date":"12-Jan-2023","totalValueINR":"77000","totalValueInUsd":"941.8","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"6903217","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681669800,"product":"RIOCIGUAT-PH.EUR","address":"ALEMBIC ROAD VADODARA Contact No: 919727727339","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER OF","customerCountry":"GREECE","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"60000","totalValueFC":"11835.9","currency":"USD","unitRateINR":4850000,"date":"17-Apr-2023","totalValueINR":"970000","totalValueInUsd":"11835.9","indian_port":"AHMEDABAD AIR","hs_no":"29335990","bill_no":"9348190","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"ALEMBIC ROAD VADODARA Contact No: 919727727339, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684348200,"product":"RIOCIGUAT RG","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"WEMICHEMI CO LTD","customerCountry":"CHINA","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"35000","totalValueFC":"2066","currency":"USD","unitRateINR":2833333.3333333335,"date":"18-May-2023","totalValueINR":"170000","totalValueInUsd":"2066","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696271400,"product":"RIOCIGUAT (RG)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"TO THE ORDER OF","customerCountry":"CHINA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"35000","totalValueFC":"17241.5","currency":"USD","unitRateINR":2870000,"date":"03-Oct-2023","totalValueINR":"1435000","totalValueInUsd":"17241.5","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"4367087","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698258600,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS - (API) - RIOCIGUAT - PH.EUR","address":"ALEMBIC ROAD","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER OF","customerCountry":"GREECE","quantity":"0.50","actualQuantity":"0.495","unit":"KGS","unitRateFc":"55000","totalValueFC":"26877.6","currency":"USD","unitRateINR":4519191.9191919193,"date":"26-Oct-2023","totalValueINR":"2237000","totalValueInUsd":"26877.6","indian_port":"Ahmedabad Air","hs_no":"29415000","bill_no":"4898129","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"ALEMBIC ROAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701369000,"product":"RIOCIGUAT","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO APT\/MOS","customer":"PJSC PHARMASYNTEZ","customerCountry":"RUSSIA","quantity":"0.19","actualQuantity":"194","unit":"GMS","unitRateFc":"44.6","totalValueFC":"8566.6","currency":"USD","unitRateINR":3675.8350515463917,"date":"01-Dec-2023","totalValueINR":"713112","totalValueInUsd":"8566.6","indian_port":"Vizag-HIPL SEZ","hs_no":"29349990","bill_no":"4000961","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705516200,"product":"RIOCIGUAT (RG)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"MIAMI, FL","customer":"ACTAVIS INC","customerCountry":"UNITED STATES","quantity":"0.95","actualQuantity":"0.95","unit":"KGS","unitRateFc":"37500","totalValueFC":"35301.8","currency":"USD","unitRateINR":3088415.2631578948,"date":"18-Jan-2024","totalValueINR":"2933994.5","totalValueInUsd":"35301.8","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"6847767","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708540200,"product":"RIOCIGUAT(UJ)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"PHARMAPATH S.A","customerCountry":"GREECE","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"70000","totalValueFC":"6796.9","currency":"USD","unitRateINR":5639630,"date":"22-Feb-2024","totalValueINR":"563963","totalValueInUsd":"6796.9","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"7752734","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"RIOCIGUAT PH.EUR","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"PLIVA HRVATSKA","customerCountry":"CROATIA","quantity":"1.05","actualQuantity":"1.05","unit":"KGS","unitRateFc":"37928.6","totalValueFC":"39018.7","currency":"USD","unitRateINR":3097500,"date":"16-May-2024","totalValueINR":"3252375","totalValueInUsd":"39018.7","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9936185","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"RIOCIGUAT PH.EUR","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"PLIVA HRVATSKA","customerCountry":"CROATIA","quantity":"1.45","actualQuantity":"1.45","unit":"KGS","unitRateFc":"37810.3","totalValueFC":"53883","currency":"USD","unitRateINR":3097500,"date":"16-May-2024","totalValueINR":"4491375","totalValueInUsd":"53883","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9936185","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715797800,"product":"RIOCIGUAT PH.EUR","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"PLIVA HRVATSKA","customerCountry":"CROATIA","quantity":"1.55","actualQuantity":"1.55","unit":"KGS","unitRateFc":"37790.3","totalValueFC":"57599.1","currency":"USD","unitRateINR":3097500,"date":"16-May-2024","totalValueINR":"4801125","totalValueInUsd":"57599.1","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9936185","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718303400,"product":"RIOCIGUAT USP","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ALEXANDRIA, EL NHOUZ","customer":"PARKVILLE PHARMACEUTICALS EGYPT","customerCountry":"EGYPT","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"40000","totalValueFC":"11801.5","currency":"USD","unitRateINR":3283939.7999999998,"date":"14-Jun-2024","totalValueINR":"985181.94","totalValueInUsd":"11801.5","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"1684988","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720549800,"product":"RIOCIGUAT PH.EUR","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"CHANELLE PHARMA LAB","customerCountry":"JORDAN","quantity":"0.08","actualQuantity":"0.08","unit":"KGS","unitRateFc":"60000","totalValueFC":"4673.1","currency":"USD","unitRateINR":4882868,"date":"10-Jul-2024","totalValueINR":"390629.44","totalValueInUsd":"4673.1","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"2306536","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724178600,"product":"RIOCIGUAT (UJ)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BERKO PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"35000","totalValueFC":"34571.6","currency":"USD","unitRateINR":2899815,"date":"21-Aug-2024","totalValueINR":"2899815","totalValueInUsd":"34571.6","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"3377468","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655317800,"product":"RIOCIGUAT (REJECTION OF RAW MATERIAL) EXPORT VIDE SB NO:7700414 DT:24-01-2022","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"VERBEN S.A","supplierCountry":"INDIA","foreign_port":"NA","customer":"MSN LABORATORIES","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.1","unit":"GMS","unitRateFc":"39600","totalValueFC":"4029.4","currency":"USD","unitRateINR":"3143571.8","date":"16-Jun-2022","totalValueINR":"314357.18","totalValueInUsd":"4029.4","indian_port":"HYDERABAD AIR","hs_no":"29332990","bill_no":"9138897","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD"}]
    10-Mar-2021
    21-Aug-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Granulation

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Topical

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    US Patents

    read-more
    read-more

    01

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 10662188

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2834

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2026-12-04

    RIOCIGUAT

    US Patent Number : 7173037

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2026-12-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 11203593

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 10662188

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2834

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 10662188

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 11203593

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 11203593

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 10662188

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 11203593

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    BAYER HLTHCARE

    RIOCIGUAT

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    BAYER HLTHCARE

    Germany
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Patent Expiration Date : 2034-02-18

    RIOCIGUAT

    US Patent Number : 10662188

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 204819

    Patent Use Code : U-2835

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-02-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Riociguat Manufacturers

    A Riociguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Riociguat, including repackagers and relabelers. The FDA regulates Riociguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Riociguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Riociguat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Riociguat Suppliers

    A Riociguat supplier is an individual or a company that provides Riociguat active pharmaceutical ingredient (API) or Riociguat finished formulations upon request. The Riociguat suppliers may include Riociguat API manufacturers, exporters, distributors and traders.

    click here to find a list of Riociguat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Riociguat USDMF

    A Riociguat DMF (Drug Master File) is a document detailing the whole manufacturing process of Riociguat active pharmaceutical ingredient (API) in detail. Different forms of Riociguat DMFs exist exist since differing nations have different regulations, such as Riociguat USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Riociguat DMF submitted to regulatory agencies in the US is known as a USDMF. Riociguat USDMF includes data on Riociguat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Riociguat USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Riociguat suppliers with USDMF on PharmaCompass.

    Riociguat WC

    A Riociguat written confirmation (Riociguat WC) is an official document issued by a regulatory agency to a Riociguat manufacturer, verifying that the manufacturing facility of a Riociguat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Riociguat APIs or Riociguat finished pharmaceutical products to another nation, regulatory agencies frequently require a Riociguat WC (written confirmation) as part of the regulatory process.

    click here to find a list of Riociguat suppliers with Written Confirmation (WC) on PharmaCompass.

    Riociguat NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Riociguat as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Riociguat API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Riociguat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Riociguat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Riociguat NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Riociguat suppliers with NDC on PharmaCompass.

    Riociguat GMP

    Riociguat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Riociguat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Riociguat GMP manufacturer or Riociguat GMP API supplier for your needs.

    Riociguat CoA

    A Riociguat CoA (Certificate of Analysis) is a formal document that attests to Riociguat's compliance with Riociguat specifications and serves as a tool for batch-level quality control.

    Riociguat CoA mostly includes findings from lab analyses of a specific batch. For each Riociguat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Riociguat may be tested according to a variety of international standards, such as European Pharmacopoeia (Riociguat EP), Riociguat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Riociguat USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search